> For the complete documentation index, see [llms.txt](https://blockchain-biopharma.gitbook.io/blockchain-biopharma-product-thesis/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://blockchain-biopharma.gitbook.io/blockchain-biopharma-product-thesis/what-is-blockchain-biopharma/q2-2022-crowdsale.md).

# Q2 - 2022: Crowdsale

![THE IMPLICATIONS ARE HUGE: Our new, never before been done, collaborative platform for the development of new medicines, would change the course of history for medicine: and especially for the poor and disenfranchised of the world, such as those who suffered from #Coronavirus Vaccine-inequity. ](/files/gUVnKjkuOso4mLzex3lJ)

With Pharmaceutical R\&D Investments down in Q1 2022 due to the strain of COVID, as well as its profit opportunity to the PHARMA industry: We believe our Product Thesis proposes the best way to "course correct" these investment numbers. 

**DISCLAIMER:** As of this date, we seek only Accredited Investors and partners such as Fortune 1,000 Companies, governments, universities, and globally competitive existing pharmaceutical companies, all of whom have the **Fractionalized Intellectual Property (IP) NFT's** source patents assigned to them. We need to begin to think in genetics, pharmacogenetics, and in terms of  compounds and molecules. \
\
PHARMA Token investments are considered a **High Risk Investment** .

Additionally, this risk lies in the highly-controversial (from a legal perspective) Blockchain Industry, where Regulations are institutionally adopted, but Regulatory and Compliance constantly lie in a ***"Grey Area"*** that constantly changes as a moving target, as per disclosure, which the reader should be aware of.\
\
PHARMA Token is classified as a [#derivative](https://www.linkedin.com/feed/hashtag/?keywords=derivative\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080), and [#ALTCoin](https://www.linkedin.com/feed/hashtag/?keywords=altcoin\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080), and a [#UtilityToken](https://www.linkedin.com/feed/hashtag/?keywords=utilitytoken\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080) by US Regulatory and Compliance Agencies, all of whom we contacted as part of our US Government lobbying effort throughout the [#COVID19Pandemic](https://www.linkedin.com/feed/hashtag/?keywords=covid19pandemic\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080) .

This project's pharma, blockchain, NFT, and all other initial, Non-Profit R\&D was done as part of a **graduate school thesis** which stemmed from a necessary [#COVID19Response](https://www.linkedin.com/feed/hashtag/?keywords=covid19response\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080) on the side of #TransparentData in the Pharmaceutical, Life Science, and Nutrition Science industries.

COVID was politicized, disorganized, and in #DataScience Chaos. We iterated the approach to get #BioTech right. <br>

![](/files/FXio34YQayDqZm0sG31o)